Prevention of Chemotherapy-induced Peripheral Neuropathy With Therapeutic Exercise and Blood Flow Restriction Using PRESIONA Program
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:
• 18 years or older
• HER2+ breast cancer diagnosis
• On the waiting list to anticancer medical treatment (taxanes-based neoadjuvant chemotherapy)
Locations
Other Locations
Spain
University of Granada
RECRUITING
Granada
Contact Information
Primary
Irene Cantarero-Villanueva, PhD
irenecantarero@ugr.es
958248764
Time Frame
Start Date: 2021-01-01
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 25
Treatments
Experimental: PRESIONA
An adapted therapeutic exercise program using blood flow restriction cuff perfomed during chemotherapy treatment. 24-36 sessions of 1 hour multimodal components: aerobic, strength and fascial release exercises. Frequency will be adapted to the recovery status of each patient.
No_intervention: Control group
Patients undergoing usual medical treatment
Related Therapeutic Areas
Sponsors
Leads: Universidad de Granada